Carregant...

No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis

The use of tumour necrosis factor (TNF) antagonists (infliximab [IFN], etanercept [ETN], adalimumab [ADA]) has changed the course of many rheumatic diseases, including rheumatoid arthritis (RA). However, some questions concerning their safety have emerged since their approval because they can trigge...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Benucci, Maurizio, Saviola, Gianantonio, Meacci, Francesca, Manfredi, Mariangela, Infantino, Maria, Campi, Paolo, Severino, Maurizio, Iorno, Miriam, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola
Format: Artigo
Idioma:Inglês
Publicat: Bentham Open 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3793582/
https://ncbi.nlm.nih.gov/pubmed/24115967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312901307010075
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!